SANDEEP AGARWAL to Antirheumatic Agents
This is a "connection" page, showing publications SANDEEP AGARWAL has written about Antirheumatic Agents.
Connection Strength
1.473
-
Core management principles in rheumatoid arthritis to help guide managed care professionals. J Manag Care Pharm. 2011 Nov-Dec; 17(9 Suppl B):S03-8.
Score: 0.325
-
Biologic agents in rheumatoid arthritis: an update for managed care professionals. J Manag Care Pharm. 2011 Nov-Dec; 17(9 Suppl B):S14-8.
Score: 0.325
-
Predictors of discontinuation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis. J Rheumatol. 2008 Sep; 35(9):1737-44.
Score: 0.259
-
Real-world Comparative Effectiveness of Methotrexate-based Combinations for Rheumatoid Arthritis: A Retrospective Cohort Study. Clin Ther. 2023 09; 45(9):e177-e186.
Score: 0.184
-
Risk of incident cardiovascular events with disease-modifying anti-rheumatic drugs among adults with rheumatoid arthritis: a nested case-control study. Clin Rheumatol. 2024 Jan; 43(1):103-116.
Score: 0.183
-
A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate. Ann Rheum Dis. 2017 May; 76(5):831-839.
Score: 0.116
-
Assessment of disease activity and treatment outcomes in rheumatoid arthritis. J Manag Care Pharm. 2011 Nov-Dec; 17(9 Suppl B):S09-13.
Score: 0.081